MED Relative Valuation
MED's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, MED is overvalued; if below, it's undervalued.
Historical Valuation
Medifast Inc (MED) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of 11.38. The fair price of Medifast Inc (MED) is between NaN to NaN according to relative valuation methord.
Relative Value
Fair Zone
NaN-NaN
Current Price：10.80
Fair
-6.43
PE
1Y
3Y
5Y
Trailing
Forward
3.85
EV/EBITDA
Medifast Inc. (MED) has a current EV/EBITDA of 3.85. The 5-year average EV/EBITDA is 6.93. The thresholds are as follows: Strongly Undervalued below -0.73, Undervalued between -0.73 and 3.10, Fairly Valued between 10.76 and 3.10, Overvalued between 10.76 and 14.58, and Strongly Overvalued above 14.58. The current Forward EV/EBITDA of 3.85 falls within the Historic Trend Line -Fairly Valued range.
1.72
EV/EBIT
Medifast Inc. (MED) has a current EV/EBIT of 1.72. The 5-year average EV/EBIT is 7.95. The thresholds are as follows: Strongly Undervalued below -18.21, Undervalued between -18.21 and -5.13, Fairly Valued between 21.02 and -5.13, Overvalued between 21.02 and 34.10, and Strongly Overvalued above 34.10. The current Forward EV/EBIT of 1.72 falls within the Historic Trend Line -Fairly Valued range.
0.34
PS
Medifast Inc. (MED) has a current PS of 0.34. The 5-year average PS is 0.98. The thresholds are as follows: Strongly Undervalued below -0.13, Undervalued between -0.13 and 0.42, Fairly Valued between 1.53 and 0.42, Overvalued between 1.53 and 2.09, and Strongly Overvalued above 2.09. The current Forward PS of 0.34 falls within the Undervalued range.
0.00
P/OCF
Medifast Inc. (MED) has a current P/OCF of 0.00. The 5-year average P/OCF is 9.99. The thresholds are as follows: Strongly Undervalued below -1.60, Undervalued between -1.60 and 4.20, Fairly Valued between 15.79 and 4.20, Overvalued between 15.79 and 21.59, and Strongly Overvalued above 21.59. The current Forward P/OCF of 0.00 falls within the Undervalued range.
-7.59
P/FCF
Medifast Inc. (MED) has a current P/FCF of -7.59. The 5-year average P/FCF is 16.97. The thresholds are as follows: Strongly Undervalued below -21.77, Undervalued between -21.77 and -2.40, Fairly Valued between 36.34 and -2.40, Overvalued between 36.34 and 55.71, and Strongly Overvalued above 55.71. The current Forward P/FCF of -7.59 falls within the Undervalued range.
Medifast Inc (MED) has a current Price-to-Book (P/B) ratio of 0.53. Compared to its 3-year average P/B ratio of 2.77 , the current P/B ratio is approximately -80.96% higher. Relative to its 5-year average P/B ratio of 6.98, the current P/B ratio is about -92.45% higher. Medifast Inc (MED) has a Forward Free Cash Flow (FCF) yield of approximately 0.00%. Compared to its 3-year average FCF yield of 17.78%, the current FCF yield is approximately -100.00% lower. Relative to its 5-year average FCF yield of 12.47% , the current FCF yield is about -100.00% lower.
0.52
P/B
Median3y
2.77
Median5y
6.98
0.57
FCF Yield
Median3y
17.78
Median5y
12.47
Competitors Valuation Multiple
The average P/S ratio for MED's competitors is 0.00, providing a benchmark for relative valuation. Medifast Inc Corp (MED) exhibits a P/S ratio of , which is NaN% above the industry average. Given its robust revenue growth of -36.21%, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap
Performance Decomposition
1Y
3Y
5Y
Market capitalization of MED decreased by 38.37% over the past 1 year. The primary factor behind the change was an increase in P/E Change from 106.67 to 544.22.
The secondary factor is the Revenue Growth, contributed -36.21%to the performance.
Overall, the performance of MED in the past 1 year is driven by P/E Change. Which is more unsustainable.
People Also Watch
FAQ
Is Medifast Inc (MED) currently overvalued or undervalued?
What is Medifast Inc (MED) fair value?
How does MED's valuation metrics compare to the industry average?
What is the current P/B ratio for Medifast Inc (MED) as of Dec 05 2025?
What is the current FCF Yield for Medifast Inc (MED) as of Dec 05 2025?
What is the current Forward P/E ratio for Medifast Inc (MED) as of Dec 05 2025?